ArticleIrish journal of medical science2026
The A-VIVO score: a novel prognostic tool for predicting mortality in patients with sepsis.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSepsis is a life-threatening clinical syndrome associated with high morbidity and mortality in patients admitted to intensive care units. Early prediction of mortality risk is essential for timely interventions and optimal use of critical care resources. Although various prognostic scoring systems are available, many are complex or not easily applicable in daily clinical practice. Therefore, simple and reliable tools for early risk stratification are needed.
aimsThe aim of this study was to evaluate the prognostic performance of the A-VIVO score in predicting early mortality in patients with sepsis.
methodsThis retrospective, single-center observational study reviewed electronic medical records of adult patients diagnosed with sepsis according to the Sepsis-3 criteria and admitted to the intensive care unit between January 2020 and January 2025. Patients aged 18 years or older who were monitored for at least 48 h were included. Patients with missing data or unavailable mortality outcomes were excluded. Patients were classified as survivors or non-survivors based on 30-day mortality. The A-VIVO score was calculated using eight clinical and laboratory parameters, each scored from 0 to 2 points.
resultsA total of 683 patients were included. Of these, 400 patients (58.6%) died within 30 days, while 283 patients (41.4%) survived. The A-VIVO score was significantly higher in non-survivors and showed a strong association with mortality.
conclusionsThe A-VIVO score is a simple and practical tool for predicting mortality in patients with sepsis and may support early clinical decision-making.
Indexed as
Identifiers
42268338What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.